Cargando…
Optimal Duration of Adjuvant Chemotherapy for Gastric Cancer: Might Less Be More?
Autor principal: | Han, Hye Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Gastric Cancer Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091460/ https://www.ncbi.nlm.nih.gov/pubmed/35534445 http://dx.doi.org/10.5230/jgc.2022.22.e13 |
Ejemplares similares
Ejemplares similares
-
Optimal Duration of Fluorouracil-Based Adjuvant Chemotherapy for Patients with Resectable Gastric Cancer
por: Qu, Jing-lei, et al.
Publicado: (2013) -
The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
por: Collienne, Maike, et al.
Publicado: (2020) -
COVID-19: When more might be less
por: Mugnai, Giacomo, et al.
Publicado: (2021) -
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2022) -
Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)